Highlights Bio-Rad Laboratories, Inc.

Stocks

BIO

US0905722072

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 16:00:03 2026-07-31 EDT			5-day change	1st Jan Change
325.48 ^USD	-0.38%		+3.50%	+7.42%

07-01	Activist investors make bigger push for campaigns in H1, seek more M&A	RE
06-03	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM

Highlights

04-30	Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises	MT
04-30	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q1 Revenue $592.1M, vs. FactSet Est of $589.9M	MT
04-30	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q1 Adjusted EPS $1.89 per Share, vs. FactSet Est of $1.97	MT
04-30	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
04-30	Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-12	Bio-Rad Laboratories Q4 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours	MT
02-12	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M	MT
02-12	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q4 Adjusted EPS $2.51 per Share, vs. FactSet Est of $2.71	MT
02-12	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
02-12	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
25-10-30	Bio-Rad Laboratories Q3 Non-GAAP Earnings, Revenue Rise	MT
25-10-29	Bio-Rad Q3 profit beats estimates helped by cost management	RE
25-10-29	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q3 Revenue $653.0M, vs. FactSet Est of $652.2M	MT
25-10-29	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q3 Adjusted EPS $2.26 per Share, vs. FactSet Est of $1.95	MT
25-10-29	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
25-10-29	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-16	Bio-Rad to report third quarter 2025 financial results	RE
25-08-01	Bio-Rad Laboratories Shares Rise After Price Target Boosts Post-Q2 Beat	MT
25-07-31	Bio-Rad Laboratories Q2 Tops Estimates; Updates Guidance	MT
25-07-31	Bio-Rad Q2 revenue up 2.1%, beats estimates	RE
25-07-31	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.61 per Share, vs. FactSet Est of $1.73	MT
25-07-31	Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.6M, vs. FactSet Est of $615.2M	MT
25-07-31	Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	CI
25-07-31	Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-07-07	Bio-Rad Laboratories, Inc. Announces Launch of Four New Droplet Digital?? PCR (ddPCR??) Platforms	CI